3 unchanged sentences
ADMA Biologics, Inc.
−Removed: November 10, 2021
President and Chief Executive Officer
−Removed: November 10, 2021
/s/ Brian Lenz
2 unchanged sentences
Exhibit Number
−Removed: Distribution Agreement, dated September 3, 2021, by and between ADMA Biologics, Inc.
−Removed: and Raymond James & Associates, Inc.
−Removed: (incorporated by reference to Exhibit 1.1 of the Company’s Current Report on
−Removed: Form 8-K filed with the SEC on September 3, 2021).
−Removed: Form of Retention Bonus Agreement (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on October 1, 2021).
−Removed: Amendment to Employment Agreement, dated as of September 29, 2021, by and between the Company and Adam Grossman (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed
−Removed: with the SEC on October 1, 2021).
−Removed: Amendment to Employment Agreement, dated as of September 29, 2021, by and between the Company and Brian Lenz (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed with
−Removed: the SEC on October 1, 2021).
+Added: Form of Warrant to Purchase Stock, in the form issued by the Company to various entities affiliated with Hayfin Services LLP, dated as of March 23, 2022 (incorporated by reference to Exhibit 4.13 to the
+Added: Company’s Annual Report on Form 10-K, filed with the SEC on March 24, 2022.
+Added: Credit Agreement and Guaranty, dated as of March 23, 2022, by and among the Company, Hayfin Services LLP and the lenders party thereto (incorporated by reference to Exhibit 10.24 to the Company’s Annual
+Added: Report on Form 10-K, filed with the SEC on March 24, 2022).
+Added: Security Agreement, dated as of March 23, 2022, by and among the Company, certain subsidiaries of the Company and Hayfin Services LLP (incorporated by reference to Exhibit 10.25 to the Company’s Annual
+Added: Report on Form 10-K, filed with the SEC on March 24, 2022).
Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
2 unchanged sentences
Certification of Principal Financial Officer pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: The following materials from ADMA Biologics, Inc.’s Form 10-Q for the quarter ended September 30, 2021, formatted in Extensible Business Reporting Language (XBRL):
−Removed: (i) Condensed Consolidated Balance Sheets
−Removed: as of September 30, 2021 (Unaudited) and December 31, 2020, (ii) Condensed Consolidated Statements of Operations (Unaudited) for the three and nine months ended September 30, 2021 and 2020, (iii) Condensed Consolidated Statements of
−Removed: Changes in Stockholders’ Equity (Unaudited) for the three and nine months ended September 30, 2021 and 2020, (iv) Condensed Consolidated Statements of Cash Flows (Unaudited) for the nine months ended September 30, 2021 and 2020, and (v)
−Removed: Notes to (Unaudited) Condensed Consolidated Financial Statements.
+Added: The following materials from ADMA Biologics, Inc.’s Form 10-Q for the quarter ended March 31, 2022, formatted in Extensible Business Reporting Language (XBRL):
+Added: (i) Condensed Consolidated Balance Sheets as
+Added: of March 31, 2022 (Unaudited) and December 31, 2021, (ii) Condensed Consolidated Statements of Operations (Unaudited) for the three months ended March 31, 2022 and 2021, (iii) Condensed Consolidated Statements of Changes in Stockholders’
+Added: Equity (Unaudited) for the three months ended March 31, 2022 and 2021, (iv) Condensed Consolidated Statements of Cash Flows (Unaudited) for the three months ended March 31, 2022 and 2021, and (v) Notes to (Unaudited) Condensed
+Added: Consolidated Financial Statements.
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.